Public consultation on interim decisions to amend the Poisons Standard - ACMS, June 2021

Closed 1 Nov 2021

Opened 30 Sep 2021

Feedback updated 5 Dec 2022

We asked

Between 30 September 2021 to 1 November 2021, we sought submissions from the public on the interim decisions made for the substances discussed at the June 2021 meeting of the Advisory Committee on Medicines Scheduling. Respondents were given the choice to indicate their support or opposition to the proposed amendments using survey buttons, with or without a written response.

You said

We received 3 responses, all with written components which contained comments pertaining to amygdalin and hydrocyanic acid and ibuprofen. No submissions were received with respect to bufexamac.

We did

The Delegate of the Secretary of the Department of Health and Aged Care that is responsible for medicines scheduling considered all submissions prior to making a final decision on these proposals. The final decisions on the proposed amendments to the Poisons Standard were published on 20 December 2021.  

Published responses

View submitted responses where consent has been given to publish the response.

Overview

Scheduling amendments referred to expert advisory committee

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-24 June 2021 meeting of the Advisory Committee on Medicines Scheduling (ACMS).

The closing date for this consultation is close of business 1 November 2021. All submissions received by the deadline will be considered by the delegate before they make a final decision.

The interim decisions under consultation are detailed in the public notice of interim decisions of June 2021.

Substances for which public comment is sought

  • Item 1.1 - Amygdalin and hydrocyanic acid
  • Item 1.2 - Bufexamac
  • Item 1.3 - Ibuprofen

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committees, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions  in December 2021.

 

Audiences

  • General public

Interests

  • Legislation